Joe Binder is a corporate associate and a member of the firm’s Investment Management Group. His practice focuses on advising sponsors of private investment funds, including buyout, credit opportunities and direct lending, real estate and venture funds. Mr. Binder’s recent experience includes acting for clients such as Crescent Capital Group, HarbourVest Partners, Morgan Stanley, One Rock Capital, Sequoia Capital and Stone Point Capital.
Mr. Binder joined Debevoise in 2013. He earned his J.D. from Brooklyn Law School summa cum laude in 2013. Mr. Binder is the co-author of “A Model for Measuring the Expected Value of Assuming Tax-Partnership Liability,” an article published by the Brooklyn Journal of Corporate, Financial & Commercial Law in 2013.
He received a B.A. magna cum laude from Northeastern Illinois University in 2008. Prior to law school, Mr. Binder worked as a communications consultant to nonprofit organizations in New York, Washington, D.C., and Chicago.
- Johnson & Johnson in its acquisition of Zarbee’s Naturals, a leader in naturally-based healthcare products.
- One Rock Capital Partners in the formation of One Rock Capital Partners II, a $964 million U.S. buyout fund.
- Solenis, a Clayton, Dubilier & Rice portfolio company, in its combination with BASF’s paper and water chemicals business.
- The Carlyle Group in its strategic minority investment in DiscoverOrg, the leading global sales and marketing intelligence platform.
- HarbourVest Partners in the formation of HarbourVest Real Assets III, a $366 million global secondaries fund.
- Morgan Stanley Investment Management in its acquisition of Manna Pro, a leading producer of nutritional supplements and other animal products, from The Carlyle Group.
- Clayton, Dubilier & Rice in its acquisition of a majority interest in American Greetings.
- The Carlyle Group in its acquisition of MedRisk, a provider of managed physical medicine to the workers’ compensation industry.
- Global Atlantic in the reinsurance of $9 billion of fixed annuities and other spread-based reserves of Talcott Resolution, The Hartford’s run-off life and annuity businesses.
- Bedrock Insurance in its proposed acquisition of Ashmere Insurance, a workers’ compensation specialty insurance company.
- Sawai Pharmaceutical in the sale of a minority stake of its U.S. subsidiary, Upsher-Smith Laboratories, to Japanese trading house Sumitomo.
- Mitsui in its acquisition of an additional 10% limited partnership interest in Penske Truck Leasing from subsidiaries of GE Capital Global Holdings.
- Wilton Re in its acquisition of Aegon Transamerica’s two largest U.S. run-off businesses.
- Citizens Financial in its acquisition of Western Reserve Partners, a merger and acquisition advisory firm.
- Clayton, Dubilier & Rice in the acquisition of Carestream Dental, the digital dental business of Carestream Health.
- One Equity Partners in the formation of One Equity Partners VI, a $1.65 billion U.S. and Western Europe buyout fund.
- Empowerment Ventures and its wholly-owned subsidiary UniRush, a pioneer in the development of reloadable prepaid debit cards, in the sale of UniRush to Green Dot.
- Morgan Stanley Investment Management in the formation of North Haven Capital Partners VI, a $1.5 billion global buyout fund.
- Crescent Capital Group in the formation of Crescent Mezzanine Partners VII, a $4.6 billion U.S. mezzanine fund.
- PharMEDium, a Clayton, Dubilier & Rice portfolio company and the leading national provider of outsourced compounded sterile preparations to acute care hospitals in the United States, in its $2.6 billion sale to AmerisourceBergen.
- Envision Healthcare in its $15 billion merger with AMSURG, creating one of the largest U.S. providers of specialty physicians and hospital-related services.
- Providence Service Corporation in a strategic partnership with Frazier Healthcare Partners in Matrix Medical Network.
- Clayton, Dubilier & Rice in its acquisition of a controlling stake in Drive DeVilbiss Healthcare, a global manufacturer of medical products.
- Morgan Stanley Private Equity in its investment in Pathway Partners, a leading veterinary hospital owner and operator.
- Littlejohn & Co. in the sale of a minority interest in the firm’s management companies and general partners to Goldman Sachs Alternative Investments & Manager Selection (AIMS) Group.
- Morgan Stanley Infrastructure Partners in the formation of North Haven Infrastructure Partners II, a $3.6 billion global infrastructure fund.
- One Equity Partners, the principal investment arm of JPMorgan, in its spin-out and related primary and secondary transactional matters.
- TIAA-CREF in its $6.25 billion acquisition of Nuveen Investments, a diversified investment management company with $221 billion in assets under management.
- Brooklyn Law School, 2013, J.D.
- Northeastern Illinois University, 2008, B.A.
- New York
Rate : $$$$